Literature DB >> 15155509

Primary angioplasty should be first line treatment for acute myocardial infarction: AGAINST.

Kevin S Channer1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15155509      PMCID： PMC416610          DOI： 10.1136/bmj.328.7450.1256

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

1.  Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register.

Authors:  N Brown; T Young; D Gray; A M Skene; J R Hampton
Journal:  BMJ       Date:  1997-07-19

2.  Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. The GISSI Investigators.

Authors:  M G Franzosi; E Santoro; C De Vita; E Geraci; A Lotto; A P Maggioni; F Mauri; F Rovelli; L Santoro; L Tavazzi; G Tognoni
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690

3.  ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors:  C Baigent; R Collins; P Appleby; S Parish; P Sleight; R Peto
Journal:  BMJ       Date:  1998-05-02

4.  Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland.

Authors:  S Capewell; B M Livingston; K MacIntyre; J W Chalmers; J Boyd; A Finlayson; A Redpath; J P Pell; C J Evans; J J McMurray
Journal:  Eur Heart J       Date:  2000-11       Impact factor: 29.983

5.  Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.

Authors:  C P Cannon; C M Gibson; C T Lambrew; D A Shoultz; D Levy; W J French; J M Gore; W D Weaver; W J Rogers; A J Tiefenbrunn
Journal:  JAMA       Date:  2000-06-14       Impact factor: 56.272

6.  Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.

Authors:  E Boersma; A C Maas; J W Deckers; M L Simoons
Journal:  Lancet       Date:  1996-09-21       Impact factor: 79.321

7.  A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction.

Authors:  C B Granger; H D White; E R Bates; E M Ohman; R M Califf
Journal:  Am J Cardiol       Date:  1994-12-15       Impact factor: 2.778

8.  ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1992-03-28       Impact factor: 79.321

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

Review 10.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321
View more
  1 in total

1.  Reducing mortality in myocardial infarction.

Authors:  Jonathan N Townend; Sagar N Doshi
Journal:  BMJ       Date:  2005-04-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.